Search

everythinglearnresearchcommunity

for

Search:↓

Reticular erythematous mucinosis syndrome can occur with minimal mucin deposition.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

A woman with lupus developed rare skin growths that went away on their own.

Fever and rash can be early signs of lupus.

Ixekizumab effectively treated severe psoriasis and hair loss in a patient.

Adalimumab improved folliculitis decalvans in most patients.

TNF-alpha inhibitors can cause various immune-related skin issues.

Skin symptoms like rashes and hives can help identify COVID-19 early.

The document suggests doctors should watch for bone marrow suppression and severe hair loss in patients treated with Azathioprine.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

COVID-19 can cause various skin symptoms, including rashes and lesions, which often appear early and can help in timely diagnosis.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Eating shiitake mushrooms caused a man to develop a rash similar to a skin condition known as AGEP.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Finasteride, a hair loss drug, caused a skin rash that went away when the drug was stopped and returned when used again.

Combining glucocorticoids with immunosuppressants like cyclophosphamide improves remission and reduces relapse in pemphigus patients.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

A patient's allergic reaction to clozapine resolved without stopping the medication, showing the importance of blood monitoring.

A 68-year-old man improved after being correctly diagnosed and treated for a skin condition caused by mites, following a stem cell transplant.